SEC Filings

Filing date	Form	Description	View
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004326.pdf 0001415889-22-004326.rtf 0001415889-22-004326.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004328.pdf 0001415889-22-004328.rtf 0001415889-22-004328.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004330.pdf 0001415889-22-004330.rtf 0001415889-22-004330.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004332.pdf 0001415889-22-004332.rtf 0001415889-22-004332.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004334.pdf 0001415889-22-004334.rtf 0001415889-22-004334.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004336.pdf 0001415889-22-004336.rtf 0001415889-22-004336.xls
04/28/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-004339.pdf 0001415889-22-004339.rtf 0001415889-22-004339.xls
04/21/22	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001104659-22-048217.pdf 0001104659-22-048217.rtf 0001104659-22-048217.xls
04/04/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-042207.pdf 0001104659-22-042207.rtf 0001104659-22-042207.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
03/25/22	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001104659-22-037696.pdf 0001104659-22-037696.rtf 0001104659-22-037696.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.